Avita Medical RCEL 深 滬
等待開盤 05-23 09:30:00 美东时间
4.635
+0.155
+3.46%
華盛通- 最 高4.85
- 今 開4.52
- 成交量 12.41万股
- 最 低 4.40
- 昨 收 4.48
- 總市值 1.43亿
- 52周最高 7.12
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 3.22
- 委 比 87.20%
- 總股本 3077.67万
- 歷史最高 49.11
- 量 比 0.33
- 振 幅 10.04%
- 歷史最低 3.22
- 每 手 1
- 風險率 0.84%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
电话会总结 ｜ Avita(RCEL)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据AVITA Medical业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度营收1,930万美元，同比增长4%，环比增长约10%（相比2025年第四季度），为过去一年中最高季度营收。 **盈利能力：** 毛利率81.7%，净亏损1,060万美元（每股亏损0.35美元），较上年同期净亏损1,390万美元（每股亏损0.53美元）有所改善。 **现金状况：** 季度净现金消耗990万美元，期末现金及有价证券余额1,430万美元。 **成本控制：** 运营费用2,450万美元，同比下降11%。 ## 2.
05-16 12:12
Lake Street Upgrades AVITA Medical to Buy, Raises Price Target to $6
Lake Street analyst Frank Takkinen upgrades AVITA Medical (NASDAQ:RCEL) from Hold to Buy and raises the price target from $3.5 to $6.
05-16 01:44
AVITA Medical Reports Q1 2026 Results: Full Earnings Call Transcript
AVITA Medical (NASDAQ:RCEL) released first-quarter financial results and hosted...
05-15 05:26
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
AVITA Medical Appoints Cary Vance President, CEO; Jan Stern As Board Chair, Effective Immediately
AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company, today announced that its Board of Directors has appointed Cary Vance as President and Chief Executive Officer, effective
04-30 20:52
Avita Medical names Cary Vance CEO after interim tenure
Avita Medical names Cary Vance CEO after interim tenure Avita Medical appointed Cary Vance as president, chief executive officer, effective immediately. Vance served as interim CEO since October 2025. Board elected Jan Stern Reed as chair, effective immediately. Reed has served on board since 2021.
04-30 20:50
AVITA Medical Enters Into 10-Yr Agreement With BARDA Valued At Up To $25.5M To Strengthen National Preparedness For Burn Mass Casualty Incidents
Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access to 3,000 units any time over the 10-year contract VALENCIA, Calif., April 08, 2026 (GLOBE NEWSWIRE)
04-09 04:17
美股大行评级 | 最高582美元！博通获多家机构上调目标价；GENI、Okta、Rigetti Computing、Veeva Systems、Wix.com遭多家机构下调目标价
今日重点评级关注：韦德布什：维持TScan Therapeutics"跑赢大市"评级，目标价从4美元升至5美元；HC Wainwright & Co.：维持莱斯康制药"买入"评级，目标价从4美元升至6美元
03-06 11:58
